Portfolio Companies     
You Are Here:   Home  /  Commercialize Your Innovation   /  Company Creation   / Portfolio Companies  
Print This Page      Reduce Font Size Increase Font Size
cc_banner.png

Our Portfolio Companies:
 
 
nFluids Inc.
nFluids Inc.
nFluids Inc. is an early-stage company developing cutting edge fluid additives for the oil and gas industry.






iConnectivity
iConnectivityTM
iConnectivity is a Calgary-based company with a patent pending technology designed to bridge the gap between older electronic equipment and newer devices like portable handhelds, smartphones and tablets.
www.iconnectivity.com






Circle small_c


Circle Cardiovascular Imaging Inc.
Circle Cardiovascular Imaging Inc. (“CCI”) has developed software for the cardiac imaging industry, known as cmr42. cmr42 is a scientific based program that was developed by physicians for physicians.







Parvus Therapeutics Inc.
Parvus Therapeutics Inc. is a biotechnology company focused on the development and commercialization of a nanotechnology-based therapeutic platform for the treatment of autoimmune diseases such as Type 1 Diabetes, Multiple Sclerosis and Rheumatoid Arthritis.
Parvus was featured in a Calgary Herald Article, September 18, 2012:  Biotech innovators battle deadly diseases, big challenges






zephyr sleep technologies
Zephyr Sleep Technologies Inc.
Zephyr Sleep Technologies Inc. develops products designed to monitor and analyze sleep performance and treat certain sleep disorders using patented and proprietary technology.




 


SolAeroMed
SolAeroMed is dedicated to the development of novel therapeutic strategies to treat obstructive lung diseases.








Trusted Positioning Inc.
Trusted Positioning's technology is an inertial/wireless navigation software platform that solves a fundamental problem with today's navigation and positioning technology: the ability to have continuous, accurate and affordable navigation and positioning for indoor and urban outdoor environments for both consumer and enterprise markets.







AIM Therapeutics Inc.
AIM Therapeutics is a clinical stage company pioneering a new generation of therapies for chronic inflammatory disease. AIM’s proprietary compounds exploit their discoveries related to interactions between the nervous, immune and endocrine systems to treat disease.








Profero Energy Inc.
Profero Energy Inc.'s proprietary technology accelerates a natural process of bacterial biodegeneration of oil into a commercial timescale to produce methane.
www.proferoenergy.com